These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19584271)

  • 1. The emerging role of EpCAM in cancer and stem cell signaling.
    Munz M; Baeuerle PA; Gires O
    Cancer Res; 2009 Jul; 69(14):5627-9. PubMed ID: 19584271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T; Budhu A; Forgues M; Wang XW
    Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
    Patriarca C; Macchi RM; Marschner AK; Mellstedt H
    Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EpCAM and Wnt/ β-catenin in human colon cancer.
    Zhou FQ; Qi YM; Xu H; Wang QY; Gao XS; Guo HG
    Genet Mol Res; 2015 May; 14(2):4485-94. PubMed ID: 25966221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule.
    Trzpis M; McLaughlin PM; de Leij LM; Harmsen MC
    Am J Pathol; 2007 Aug; 171(2):386-95. PubMed ID: 17600130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA.
    Hao H; Zhen Y; Wang Z; Chen F; Xie X
    Cell Biol Int; 2013 Aug; 37(8):860-4. PubMed ID: 23576466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EpCAM in carcinogenesis: the good, the bad or the ugly.
    van der Gun BT; Melchers LJ; Ruiters MH; de Leij LF; McLaughlin PM; Rots MG
    Carcinogenesis; 2010 Nov; 31(11):1913-21. PubMed ID: 20837599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EpCAM a proteolytically cleaved oncogene and an excellent therapeutic target in cancer].
    Gires O
    Med Sci (Paris); 2009 May; 25(5):449-50. PubMed ID: 19480822
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the relationship among microRNA-181, epithelial cell-adhesion molecule (EpCAM) and beta-catenin in hepatic cancer stem cells.
    Li JP; Zheng JY; Du JJ; Zhang R; Yang AG
    Hepatology; 2009 Dec; 50(6):2047-8; author reply 448. PubMed ID: 19937678
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM.
    Munz M; Fellinger K; Hofmann T; Schmitt B; Gires O
    Front Biosci; 2008 May; 13():5195-201. PubMed ID: 18508581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.
    Brown TC; Sankpal NV; Gillanders WE
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EpCAM: another surface-to-nucleus missile.
    Carpenter G; Red Brewer M
    Cancer Cell; 2009 Mar; 15(3):165-6. PubMed ID: 19249674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial activation of EpCAM cleavage via cell-to-cell contact.
    Denzel S; Maetzel D; Mack B; Eggert C; Bärr G; Gires O
    BMC Cancer; 2009 Nov; 9():402. PubMed ID: 19925656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear signalling by tumour-associated antigen EpCAM.
    Maetzel D; Denzel S; Mack B; Canis M; Went P; Benk M; Kieu C; Papior P; Baeuerle PA; Munz M; Gires O
    Nat Cell Biol; 2009 Feb; 11(2):162-71. PubMed ID: 19136966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP.
    Münz M; Zeidler R; Gires O
    Cancer Lett; 2005 Jul; 225(1):151-7. PubMed ID: 15922867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis.
    Warneke VS; Behrens HM; Haag J; Krüger S; Simon E; Mathiak M; Ebert MP; Röcken C
    Br J Cancer; 2013 Oct; 109(8):2217-27. PubMed ID: 24008668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EpCAM (CD326) finding its role in cancer.
    Baeuerle PA; Gires O
    Br J Cancer; 2007 Feb; 96(3):417-23. PubMed ID: 17211480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EpCAM and the biology of hepatic stem/progenitor cells.
    Dollé L; Theise ND; Schmelzer E; Boulter L; Gires O; van Grunsven LA
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G233-50. PubMed ID: 25477371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
    Ni J; Cozzi PJ; Duan W; Shigdar S; Graham PH; John KH; Li Y
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):779-91. PubMed ID: 22718399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.